Mikami Mikio
Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan.
J Gynecol Oncol. 2014 Oct;25(4):279-81. doi: 10.3802/jgo.2014.25.4.279.
Japan Society of Gynecologic Oncology (JSGO) recently revised its Ovarian Cancer Treatment Guidelines and the 4th edition will be released next year. This Guidelines state that lymphadenectomy is essential to allow accurate assessment of the clinical stage in early ovarian cancer, but there is no randomized controlled trial that shows any therapeutic efficacy of lymphadenectomy. In patients with advanced stage tumors, lymphadenectomy should be considered if optimal debulking has been performed. I fully agree with this recommendation of the JSGO and I would like to discuss the role of lymphadenectomy in the management of ovarian cancer.
日本妇科肿瘤学会(JSGO)最近修订了其卵巢癌治疗指南,第四版将于明年发布。该指南指出,淋巴结切除术对于准确评估早期卵巢癌的临床分期至关重要,但尚无随机对照试验表明淋巴结切除术具有任何治疗效果。对于晚期肿瘤患者,如果已进行了最佳肿瘤细胞减灭术,则应考虑进行淋巴结切除术。我完全同意JSGO的这一建议,并且想讨论一下淋巴结切除术在卵巢癌治疗中的作用。